Screener
Zimmer Biomet Holdings ZBH Q2 2026 earnings
Reported August 5, 2026 · Before market open
Revenue$2.2BBeat by $42.2M
EPS$2.07Beat by $0.06
Revenue estimate$2.1B
EPS estimate$2.01
“We delivered strong second quarter results with solid top-and bottom-line performance and continued progress on our key growth drivers and commercial transformation. With a strong first half, healthy underlying markets, go-to-market changes progressing as planned and continued momentum from our innovation cycle, we are raising our revenue and adjusted EPS guidance for the year. Importantly, we continue to advance our strategic priorities and remain confident our efforts will strengthen our business, build the boldest leader in MedTech, and better position Zimmer Biomet to deliver consistent, durable growth over the long term.”
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$2.0B
EPS estimate$1.89
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Zimmer Biomet Holdings report Q2 2026 earnings?
- Zimmer Biomet Holdings (ZBH) reported Q2 2026 earnings on August 5, 2026 before market open.
- What were Zimmer Biomet Holdings's Q2 2026 revenue and EPS?
- Zimmer Biomet Holdings reported revenue of $2.2B and eps of $2.07 for Q2 2026.
- Did Zimmer Biomet Holdings beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $2.1B by $42.2M. EPS beat the consensus estimate of $2.01 by $0.06.
- How did Zimmer Biomet Holdings's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 4.8% from $2.1B a year earlier and eps grew 0.0% from $2.07.
- Where can I find Zimmer Biomet Holdings's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-333761) and the 10-Q periodic report (0001193125-26-335044) directly on SEC EDGAR. The filing index links above go to sec.gov.
